GlassScriptPhysician profile
Melvin R Manning
NPI 1326048059
$3,457.34
in general payments reported to CMS, 2019-2025
18 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
See the full distribution for Sports Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $310 · 2021: $186 · 2022: $2,498 · 2023: $60.94 · 2024: $62.02 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,495.80 | 2019-2022 | |
| Horizon Therapeutics Plc | $242.28 | 2019-2022 | |
| Ge Healthcare | $117.96 | 2020 | |
| Smith+Nephew, INC. | $102.81 | 2025 | Panta 2, Invisiknot |
| Orthofix Medical, INC. | $71.09 | 2019-2025 | Physio-Stim |
| Ferring Pharmaceuticals INC. | $69.15 | 2020-2024 | Euflexxa |
| Depuy Synthes Sales INC. | $59.79 | 2021-2024 | Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $51.24 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $47.70 | 2025 | |
| Baudax Bio INC. | $45.76 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $39.26 | 2019-2023 | Iovera |
| Ermi LLC | $25.38 | 2019 | |
| Avanos Medical | $24.01 | 2022 | |
| Biotissue Holdings INC. | $16.91 | 2021 | |
| Polynovo North America LLC | $14.30 | 2024 | Novosorb Btm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $12.85 | 2021 | |
| Assertio Therapeutics, INC. | $11.47 | 2020 | |
| Foundation Fusion Solutions, LLC | $9.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melvin Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.